Donation of Innovative Histotripsy System

Project Goals and Purpose

• The Histotripsy System is a groundbreaking non-invasive technology that uses high-intensity ultrasound to precisely destroy cancer cells without harming surrounding healthy tissue. It offers cancer patients a non-invasive, painless, and highly effective treatment option.
• Histotripsy is equipped with next-generation hardware, capable of accommodating more functions by enabling continuous system and software upgrades. The system will enable even more efficient tumour ablation by providing more objective and continuous feedback of the ablation process, laying a solid foundation for the treatment of multiple kinds of cancer.
• Through medical technology innovation, we aim to reshape the future of human health and promote the integration of global medical research and clinical applications, enhancing healthcare services and medical research through technology.
• The promise and impact of this low cost, high efficacy option tremendously lessened the financial devastation on the patients and their families, and more importantly, the fiscal burden to the government health care services in our ageing society.
• The Foundation has donated Histotripsy systems to the Li Ka Shing Faculty of Medicine at The University of Hong Kong, the Faculty of Medicine at The Chinese University of Hong Kong, and Hong Kong Sanatorium & Hospital. It also sponsors medical professionals to receive overseas training, making Hong Kong the first city in Asia to adopt this cutting-edge technology. This initiative brings new insights to cancer treatment and helps elevate local healthcare and research standards.
• Histotripsy systems have also been donated to the University of Cambridge and Stanford University. Besides, in collaboration with TT Foundation Advisors in Singapore, the system has been donated to medical institutions in Singapore—further advancing global healthcare development.